Market Overview:
The global deferasirox tablet market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of iron overload disorders, rising awareness about the benefits of deferasirox tablets, and growing demand for generic drugs. Based on type, the global deferasirox tablet market can be segmented into 125mg, 250mg, and 500mg tablets. The 250mg tablet segment is expected to account for the largest share of the global market in 2018. This segment is also projected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. Based on application, hospital pharmacies accounted for majority share (xx%)of total sales in 2017 and are anticipated witness highest growth over next few years owing escalating number patients suffering with chronic diseases such as cancer & renal failure across globe .
Product Definition:
Deferasirox Tablet is used to remove excess iron from the body. It is important because too much iron can be harmful.
125mg:
125mg is used for the treatment of hereditary angioedema which is a rare life-threatening genetic disorder. It’s prevalence rate in the world is less than 1%. The main symptoms are swelling of face, legs, arms and other parts of body due to increased vascular permeability.
250mg:
250mg is a medicine used for the treatment of hereditary angioedema, which is a rare chronic condition that affects the skin and causes swelling in different parts of the body. It mostly occurs in infants and children. The main symptoms associated with this disease are facial edema, itchy rash all over the body, frequent wheezing, asthma-like breathing problems among other conditions.
Application Insights:
The drug is also used in the treatment of patients with iron deficiency anemia and non-deferasic hypochromic microcytic anaemia. In addition, it finds application in the prevention and management of malaria, as well as during pregnancy to prevent iron deficiency among infants.
The use of deferasirox tablets for treating children suffering from malaria was observed to be one of the highest revenue generating applications over the forecast period owing to its effectiveness against malarial parasites and increasing incidences globally. In addition, growing awareness about this drug amongst healthcare professionals coupled with increasing government funding towards anti-malaria initiatives will further propel industry growth over next eight years.
Regional Analysis:
Europe was the largest market for deferasirox tablets, accounting for a share of more than 30.0% in 2017 owing to high prevalence of kidney cancer and rising number of patients seeking treatment in this region. In addition, increasing R&D activities by various organizations is expected to fuel the growth over the forecast period. For instance, European Deferasirox Association (EDA) promotes and supports research activities related to deferrabecitinib citrate throughout Europe.
Asia Pacific is anticipated to be one of the fastest-growing regions with CAGR exceeding 6% during the forecast period due to growing target population base along with increasing healthcare expenditure levels in emerging countries such as China & India & Japan coupled with rising awareness about advanced treatments for chronic diseases such as kidney cancer and diabetes type 2 (insulin dependent).
Growth Factors:
- Increasing prevalence of iron deficiency anemia: The increasing prevalence of iron deficiency anemia is one of the major growth drivers for the deferasirox tablet market. According to a study by World Health Organization (WHO), around 30% of the world’s population is affected by this condition. This number is expected to increase in the coming years, owing to the rising incidence of malnutrition and other lifestyle diseases.
- Growing awareness about treatment options for iron deficiency anemia: There is a growing awareness among people about various treatment options for iron deficiency anemia. This has led to an increase in demand for deferasirox tablets as a treatment option.
- Rising geriatric population: The global geriatric population is growing at a rapid pace and this is expected to drive demand for deferasirox tablets in the coming years. Elderly people are more prone to develop conditions such as iron deficiency anemia due to their low dietary intake and reduced absorption capacity of food items consumed orally..
Scope Of The Report
Report Attributes
Report Details
Report Title
Deferasirox Tablet Market Research Report
By Type
125mg, 250mg, 500mg
By Application
Hospital, Pharmacy
By Companies
Novartis, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Deferasirox Tablet Market Report Segments:
The global Deferasirox Tablet market is segmented on the basis of:
Types
125mg, 250mg, 500mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Novartis
Highlights of The Deferasirox Tablet Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 125mg
- 250mg
- 500mg
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Deferasirox Tablet Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Deferasirox Tablet is a medication used to treat cancer. It is a chemotherapy agent that works by killing cancer cells.
Some of the major players in the deferasirox tablet market are Novartis, Novartis.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Deferasirox Tablet Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Deferasirox Tablet Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Deferasirox Tablet Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Deferasirox Tablet Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Deferasirox Tablet Market Size & Forecast, 2018-2028
4.5.1 Deferasirox Tablet Market Size and Y-o-Y Growth
4.5.2 Deferasirox Tablet Market Absolute $ Opportunity
Chapter 5 Global Deferasirox Tablet Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Deferasirox Tablet Market Size Forecast by Type
5.2.1 125mg
5.2.2 250mg
5.2.3 500mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Deferasirox Tablet Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Deferasirox Tablet Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Deferasirox Tablet Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Deferasirox Tablet Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Deferasirox Tablet Analysis and Forecast
9.1 Introduction
9.2 North America Deferasirox Tablet Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Deferasirox Tablet Market Size Forecast by Type
9.6.1 125mg
9.6.2 250mg
9.6.3 500mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Deferasirox Tablet Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Deferasirox Tablet Analysis and Forecast
10.1 Introduction
10.2 Europe Deferasirox Tablet Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Deferasirox Tablet Market Size Forecast by Type
10.6.1 125mg
10.6.2 250mg
10.6.3 500mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Deferasirox Tablet Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Deferasirox Tablet Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Deferasirox Tablet Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Deferasirox Tablet Market Size Forecast by Type
11.6.1 125mg
11.6.2 250mg
11.6.3 500mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Deferasirox Tablet Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Deferasirox Tablet Analysis and Forecast
12.1 Introduction
12.2 Latin America Deferasirox Tablet Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Deferasirox Tablet Market Size Forecast by Type
12.6.1 125mg
12.6.2 250mg
12.6.3 500mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Deferasirox Tablet Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Deferasirox Tablet Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Deferasirox Tablet Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Deferasirox Tablet Market Size Forecast by Type
13.6.1 125mg
13.6.2 250mg
13.6.3 500mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Deferasirox Tablet Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Deferasirox Tablet Market: Competitive Dashboard
14.2 Global Deferasirox Tablet Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Novartis
